Averill Funds Sell $80.4M Veradermics Stock and Exercise 300K Warrants
MANE has more than doubled off its 52-week low of $32.
Summary
Averill Master Fund and Averill Madison Master Fund sold $80.4 million of Veradermics stock and exercised 300,000 pre-funded warrants, adding to recent insider selling pressure.
Key Events · Ownership and Investor Activity · MANE
-
Averill Funds Sell $80.4M
Averill Master Fund sold 690,601 shares and Averill Madison Master Fund sold 59,399 shares on August 19, 2026, at $107.25 per share, totaling approximately $80.4 million.
-
Warrant Exercises Add 300K Shares
On August 20, 2026, Averill Master Fund exercised 149,000 pre-funded warrants and Averill Madison Master Fund exercised 151,000 pre-funded warrants at $0.00001 per share, adding 300,000 shares to the float.
-
Insider Selling Wave Continues
This sale follows $103.1 million in open-market insider selling over the past 90 days, including a $15 million planned sale by CEO Reid Waldman and a $10.7 million sale by Director John W. Childs.
-
Ownership Stakes Reduced
After these transactions, Averill Master Fund holds 3,718,970 shares (8.8%), Averill Madison Master Fund holds 612,033 shares (1.5%), and Montanova Capital reports aggregate beneficial ownership of 3,718,970 shares (8.8%).
Analysis · MANE · Life Sciences
The Averill funds, managed by Montanova Capital, sold 750,000 shares at $107.25 on August 19, 2026, for approximately $80.4 million, and then exercised pre-funded warrants for 300,000 shares at a nominal price on August 20. This continues a wave of insider selling that has totaled over $103 million in the past 90 days, including a $15 million planned sale by the CEO. The warrant exercises add 300,000 shares to the float, increasing potential supply pressure.
At the time of this filing, MANE was trading at $102.82 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $32.00 to $131.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.